Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01343420 · ClinicalTrials.gov registry record · NA
Dog Hair Extract Study
A NA study, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01343420 is a NA study that has completed, run by National Jewish Health. The registered enrollment target is 15 participants.
The verdict
NCT01343420, a NA study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Liquid allergen extracts contain proteins, such as (but not limited to) tree, weed, cat, cockroach, and nuts, and are used to identify allergies by observing the body's reaction to the introduction of extract underneath the skin. There are a few dog allergen extracts commercially available in the US for allergy testing; however, none of these products are standardized, meaning they are not required to be the same strength. Because some extracts are not as potent (strong) as others, it's possible that some patients' allergies are misdiagnosed. Typically, the most potent (strong), but safe extract should be used so that allergic patients are correctly diagnosed. The purpose of this study is to compare the safety and potency of an investigational (not approved for use by the United States Food and Drug Administration \[FDA\]) dog allergen extract with two commercially available dog extracts, which are of differing potencies.
Interventions
- BIOLOGICAL Dog Hair Extract, ALK-Abelló, Inc.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01343420
The ClinicalTrials.gov registry entry for NCT01343420 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dog Hair Extract, ALK-Abelló, Inc. is the first listed.
NCT01343420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01343420 about?
NCT01343420 is a clinical study titled "Dog Hair Extract Study". Liquid allergen extracts contain proteins, such as (but not limited to) tree, weed, cat, cockroach, and nuts, and are used to identify allergies by observing the body's reaction to the introduction of extract underneath the skin. There are a few dog allergen extracts commercially available in the US...
What is the current status of trial NCT01343420?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2010-11. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01343420?
The interventions under investigation include: Dog Hair Extract, ALK-Abelló, Inc. (BIOLOGICAL).
Who is sponsoring clinical trial NCT01343420?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.